CYP2D6 Gene Polymorphisms and Variable Metabolic Activity in Schizophrenia Patients of Han and Tibetan Populations.

Yong-Hang LiWei HuangMan-Yu XiaoShi-Qing HuangHui ChenZai-Fang LiXue-Song LiYong Cheng

Published in: Neuropsychiatric disease and treatment (2022)

Taken together, this exploratory study showed the differences of CYP2D6 gene and metabolic polymorphism between Han and Tibetan schizophrenia patients, and therefore may improve our understanding of the pharmacogenomic response to antipsychotics in schizophrenia patients across populations.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
gene expression
patient reported outcomes
dna methylation
patient reported